Table 7. The percentages of alterations in CAP2, CAP1, CFL1, CFL2 and DSTN genes.
Cancer | CAP1 | CAP2 | CFL1 | CFL2 | DSTN |
---|---|---|---|---|---|
NEPC | 13% | 19% | 30% | 21% | 19% |
Ovarian | 11% | 12% | 2.9% | 1.3% | 2.9% |
Bladder | 11% | 9% | 2.4% | 1.6% | 0.8% |
Bladder | 10% | 9% | 1.6% | 1.6% | 0.8% |
Pancrease | 2.8% | 4% | 10% | 5% | 4% |